5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Mukka Proteins Ltd.

•
mukkaproteins.comBSE: 544135NSE: MUKKA
Market Cap₹ 962 Cr.
Current Price
High / Low₹ 33 / 18
Stock P/E13.9
Book Value₹ 17
Price to Book1.11
Dividend Yield0.00 %
ROCE11.9 %
ROE12.1 %
Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Fast Moving Consumer Goods

Hold

Rural demand proxies are mixed. Tractor sales rose 18.0% YoY (2026-07) and 2-wheelers were up 23.0% YoY (2026-06), but rural employment slowed to 1.0% YoY (2026-07), fertiliser sales were 0.0% YoY (2026-05), and food inflation of 5.52% (Jul/26) can pressure household budgets. FPI outflows remain heavy at INR -8081 crore over 3 months to 2026-08-31, limiting upside.

Confidence
62%
View full sector analysis →

PROS

  • Company has delivered good profit growth of 39.0% CAGR over last 5 years
  • Latest quarter profit grew 1072.7% YoY, showing strong momentum
  • Company has consistently been profitable over the last 5 years
  • Company has delivered good sales growth of 19.1% CAGR over last 5 years
  • Working capital cycle has improved - days down from 112 to 59

CONS

  • Company has a high debt-to-equity of 1.54x
  • Operating cash flow has been negative in recent years
  • A large part of profit comes from other income (38.2% of PBT)
  • Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -2.08x)
  • Free cash flow has been persistently negative
  • Total debt has risen sharply - up 70.5% year on year

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

Fast Moving Consumer GoodsFMCGAnimal Feed
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.GODREJAGRO675.7529.1013002.201.63128.31-13.792855.229.6820.958.85
2.AVANTIFEED799.0520.5010886.711.25116.30-37.361899.8718.2728.965.57
3.MUKKA32.0713.92962.100.0018.631072.69489.65196.9811.939.60
4.KSE177.4012.23567.687.050.94-97.55453.679.0633.62-0.05
5.AJOONI3.4713.4962.890.004.32453.14634.911930.546.532.63
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
266324502250167145296372165236635368490
258294498225158140262352156224608347463
Operating Profit830425853420912272127
OPM %3.15%9.39%0.71%10.15%5.00%3.60%11.61%5.33%5.25%5.18%4.19%5.76%5.46%
34633364365152
Interest66678911101113151516
Depreciation3333344334455
Profit before Tax10331626603220310322927
Tax %36.31%19.07%34.33%-8.63%4.89%-182.61%19.01%30.21%27.40%24.59%23.19%26.18%31.93%
Net Profit0000515271427272119
0.161.290.481.200.140.070.880.450.050.200.790.690.63

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
4095496047711,1771,3801,0061,4491,728
3855255827241,0911,2749121,3351,642
Operating Profit23242247861059511587
OPM %5.71%4.33%3.62%6.07%7.32%7.64%9.43%7.91%5.02%
28107717152928
Interest478101626375459
Depreciation25891212141718
Profit before Tax192015366687607598
Tax %27.24%31.20%28.77%28.24%27.93%15.04%20.19%24.03%26.66%
Net Profit141411264874485772
EPS0.620.620.501.102.002.341.551.74—
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%—

COMPOUNDED SALES GROWTH

10 Years:
—
5 Years:
19%
3 Years:
7%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
42%
3 Years:
6%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
—
1 Year:
12%

RETURN ON EQUITY

10 Years:
—
5 Years:
24%
3 Years:
17%
Last Year:
12%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

No bonus data found

Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital6662222303030
Minority Interest01358121630
38516176126366411469
83142159175261359447761
Trade Payables608110098131136142241
1411251728383190
Total Liabilities2012933553925759411,0761,621
48777881838493193
Capital Work in Progress024000930
95122121313756
90115150165230423564857
00000185200182
Cash & Bank12414291274260
539210711221291132243
Total Assets2012933553925759411,0761,621

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
-16-19611-45-150-112-111
Cash from Investing-23-28-14-11-3-48-35-146
Cash from Financing345413157526656267
-91281568-9110

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
73.3373.3373.3373.3373.3373.3373.3373.3373.33
5.082.812.632.632.081.701.701.701.73
2.502.001.981.981.871.660.170.000.00
Government0.000.000.000.000.000.000.000.000.00
19.0921.8522.0622.0522.7123.3124.8024.9724.93

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-12
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-12 - Mukka Proteins Limited has informed the Exchange about Schedule of Investor meet to be held on 17th September 2026

2026-09-12
Shareholders meeting

2026-09-12 - Mukka Proteins Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 10, 2026. Further, the company has informed the Exchange regarding voting results.

2026-09-10
General Updates

2026-09-10 - Mukka Proteins Limited has informed the Exchange about outcome of the AGM.

2026-09-10
Shareholders meeting

2026-09-10 - Mukka Proteins Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 10, 2026

2026-09-10
Allotment of Securities

2026-09-10 - Mukka Proteins Limited has informed the Exchange regarding allotment of 20000000 securities pursuant to Preferential Issue at its circular resolution dated September 09, 2026.

2026-09-04
Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals

2026-09-04 - Mukka Proteins Limited has informed the Exchange about Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals

2026-09-01
Acquisition

2026-09-01 - Mukka Proteins Limited has informed the Exchange about Acquisition

2026-09-01
Press Release

2026-09-01 - Mukka Proteins Limited has informed the Exchange regarding a press release dated September 01, 2026, titled "MUKKA PROTEINS LIMITED EXPANDS CIRCULAR BIO-ECONOMY FOOTPRINT: SCALING BENGALURU S WET WASTE CONVERSION INTO HIGH-VALUE INSECT PROTEIN, OIL, COMPOST, AND HUMIC ACID".

2026-08-28
Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals

2026-08-28 - Mukka Proteins Limited has informed the Exchange about receipt of in-principle approvals from NSE & BSE for issue of convertible warrants to non-promoter category on a preferential basis.

News

Recent coverage and analyst commentary for MUKKA

Loading news…

🤖

AI Stock Analyst

Mukka Proteins Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme


5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login